ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,895Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 11

$553K Total Retail Price of All Prescriptions

Rank: 2 out of 11

308 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 308 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

19% of this provider’s 308 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 8,864 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 459 436 1 1
AMLODIPINE BESYLATE 321 304 2 7
HYDROCODONE-ACETAMINOPHEN 317 267 S3 3 5
FUROSEMIDE 239 216 4 2
POTASSIUM CHLORIDE 235 229 5 8
OMEPRAZOLE 229 220 6 12
CITALOPRAM HBR 217 206 7 11
METOPROLOL SUCCINATE 204 193 8 26
LISINOPRIL 181 172 9 4
WARFARIN SODIUM 162 162 10 3
METOPROLOL TARTRATE 157 149 11 10
SIMVASTATIN 153 142 12 6
GABAPENTIN 150 122 13 9
HYDROCHLOROTHIAZIDE 146 138 14 21
METFORMIN HCL 143 128 15 16
LOSARTAN POTASSIUM 128 118 16 25
ATORVASTATIN CALCIUM 122 83 17 39
CARVEDILOL 117 114 18 15
PANTOPRAZOLE SODIUM 107 88 19 51
NAMENDA 104 104 20 13
PRAVASTATIN SODIUM 104 104 20 72
DILTIAZEM 24HR CD 97 96 22 46
LOVASTATIN 95 78 23 48
CLOPIDOGREL 94 87 24 40
PREDNISONE 90 70 25 36
SYNTHROID 88 83 26 143
MELOXICAM 85 78 27 76
ATENOLOL 83 83 28 33
VOLTAREN 81 80 29 112
SERTRALINE HCL 72 72 30 19
ALLOPURINOL 72 72 30 32
NEXIUM 72 54 30 80
TRAZODONE HCL 67 42 33 30
GLIPIZIDE 66 57 34 55
CIPROFLOXACIN HCL 62 54 35 58
DONEPEZIL HCL 62 62 35 14
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 60 35 70
QUETIAPINE FUMARATE 62 42 35 23
ALENDRONATE SODIUM 61 56 39 47
JANUVIA 55 55 40 119
ESCITALOPRAM OXALATE 55 46 40 37
DIGOXIN 54 53 42 28
PLAVIX 54 48 42 62
CYMBALTA 54 35 42 27
TRIMETHOPRIM 53 53 45 180
SUCRALFATE 53 39 45 117
CARBIDOPA-LEVODOPA 52 52 47 35
EXELON 52 52 47 44
NAPROXEN 51 41 49 106
ZOLPIDEM TARTRATE 51 49 49 65
CLONIDINE HCL 50 35 51 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.